Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deffered Revenue (2016 - 2017)

Historic Non-Current Deffered Revenue for Amphastar Pharmaceuticals (AMPH) over the last 5 years, with Q3 2017 value amounting to $1.2 million.

  • Amphastar Pharmaceuticals' Non-Current Deffered Revenue rose 62321.43% to $1.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $1.2 million, marking a year-over-year increase of 62321.43%. This contributed to the annual value of $97000.0 for FY2016, which is 9275.58% down from last year.
  • Amphastar Pharmaceuticals' Non-Current Deffered Revenue amounted to $1.2 million in Q3 2017, which was up 62321.43% from $423000.0 recorded in Q2 2017.
  • Amphastar Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $2.6 million during Q4 2013, with a 5-year trough of $97000.0 in Q4 2016.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Non-Current Deffered Revenue value was $1.3 million (recorded in 2015), while the average stood at $1.3 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first tumbled by 9275.58% in 2016, then soared by 62321.43% in 2017.
  • Over the past 5 years, Amphastar Pharmaceuticals' Non-Current Deffered Revenue (Quarter) stood at $2.6 million in 2013, then dropped by 24.5% to $2.0 million in 2014, then plummeted by 32.44% to $1.3 million in 2015, then crashed by 92.76% to $97000.0 in 2016, then surged by 1152.58% to $1.2 million in 2017.
  • Its Non-Current Deffered Revenue was $1.2 million in Q3 2017, compared to $423000.0 in Q2 2017 and $280000.0 in Q1 2017.